| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Ciprofloxacin | FAERS: 5 | US FAERS | |
| 2 | carbidopa, levodopa drug combination | FAERS: 4 | US FAERS | |
| 3 | Pregabalin | FAERS: 2 | US FAERS | |
| 4 | Levetiracetam | FAERS: 1 | US FAERS | |
| 5 | Metronidazole | FAERS: 1 | US FAERS | |
| 6 | Norgestrel | FAERS: 1 | US FAERS | |
| 7 | Rivastigmine | FAERS: 1 | US FAERS | |
| 8 | Sunitinib | FAERS: 1 | US FAERS | |
| 9 | Terbinafine | FAERS: 1 | US FAERS | |
| 10 | Zolpidem | FAERS: 1 | US FAERS | |
| 11 | aripiprazole lauroxil | FAERS: 1 | US FAERS | |
| 12 | 2-(Tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydron;chloride | Canada Vigilance: 1 | Canada Vigilance | |
| 13 | Fluoxetine | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.